Tongtong Y, Shenghua H, Yin W, Lin C, et al. Effectiveness and Safety of Dolutegravir Versus Efavirenz-Based Antiviral Regimen in People Living With HIV-1 in Sichuan Province of China: A Real-World Study. J Acquir Immune Defic Syndr 2022;91.
PMID: 36094508